Clinical Trial Update: Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients [Phase 2, Phase 3]

View source ↗

Summary

A completed phase 2/3 trial investigating the effectiveness and safety of an isothymol or carvacrol compound for COVID-19 patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Acute Respiratory Distress Syndrome
• COVID-19 Lower Respiratory Infection
• COVID-19 Pneumonia
• COVID-19 Respiratory Infection

Drugs mentioned

• Isothymol or Carvacrol compound

Snippet

Sponsor: Instituto Venezolano de Investigaciones Cientificas | Conditions: COVID-19, COVID-19 Pneumonia | Phase 2, Phase 3 | Status: COMPLETED